Cargando…
TCT CONNECT-213 Clinical Characteristics and Outcomes of Patients With COVID-19 and STEMI Treated With Fibrinolytic Therapy
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581411/ http://dx.doi.org/10.1016/j.jacc.2020.09.228 |
| _version_ | 1783598972835725312 |
|---|---|
| author | Hamadeh, Anas Aldujeli, Ali Briedis, Kasparas Tecson, Kristen Sanchez, Jorge Sanz Al Dujeili, Montazar Al-Obeidi, Ammar Diez-Gil, Jose L. Zaliunas, Remigijus Stoler, Robert McCullough, Peter |
| author_facet | Hamadeh, Anas Aldujeli, Ali Briedis, Kasparas Tecson, Kristen Sanchez, Jorge Sanz Al Dujeili, Montazar Al-Obeidi, Ammar Diez-Gil, Jose L. Zaliunas, Remigijus Stoler, Robert McCullough, Peter |
| author_sort | Hamadeh, Anas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7581411 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75814112020-10-23 TCT CONNECT-213 Clinical Characteristics and Outcomes of Patients With COVID-19 and STEMI Treated With Fibrinolytic Therapy Hamadeh, Anas Aldujeli, Ali Briedis, Kasparas Tecson, Kristen Sanchez, Jorge Sanz Al Dujeili, Montazar Al-Obeidi, Ammar Diez-Gil, Jose L. Zaliunas, Remigijus Stoler, Robert McCullough, Peter J Am Coll Cardiol Article Published by Elsevier Inc. 2020-10-27 2020-10-22 /pmc/articles/PMC7581411/ http://dx.doi.org/10.1016/j.jacc.2020.09.228 Text en Copyright © 2020 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Hamadeh, Anas Aldujeli, Ali Briedis, Kasparas Tecson, Kristen Sanchez, Jorge Sanz Al Dujeili, Montazar Al-Obeidi, Ammar Diez-Gil, Jose L. Zaliunas, Remigijus Stoler, Robert McCullough, Peter TCT CONNECT-213 Clinical Characteristics and Outcomes of Patients With COVID-19 and STEMI Treated With Fibrinolytic Therapy |
| title | TCT CONNECT-213 Clinical Characteristics and Outcomes of Patients With COVID-19 and STEMI Treated With Fibrinolytic Therapy |
| title_full | TCT CONNECT-213 Clinical Characteristics and Outcomes of Patients With COVID-19 and STEMI Treated With Fibrinolytic Therapy |
| title_fullStr | TCT CONNECT-213 Clinical Characteristics and Outcomes of Patients With COVID-19 and STEMI Treated With Fibrinolytic Therapy |
| title_full_unstemmed | TCT CONNECT-213 Clinical Characteristics and Outcomes of Patients With COVID-19 and STEMI Treated With Fibrinolytic Therapy |
| title_short | TCT CONNECT-213 Clinical Characteristics and Outcomes of Patients With COVID-19 and STEMI Treated With Fibrinolytic Therapy |
| title_sort | tct connect-213 clinical characteristics and outcomes of patients with covid-19 and stemi treated with fibrinolytic therapy |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581411/ http://dx.doi.org/10.1016/j.jacc.2020.09.228 |
| work_keys_str_mv | AT hamadehanas tctconnect213clinicalcharacteristicsandoutcomesofpatientswithcovid19andstemitreatedwithfibrinolytictherapy AT aldujeliali tctconnect213clinicalcharacteristicsandoutcomesofpatientswithcovid19andstemitreatedwithfibrinolytictherapy AT briediskasparas tctconnect213clinicalcharacteristicsandoutcomesofpatientswithcovid19andstemitreatedwithfibrinolytictherapy AT tecsonkristen tctconnect213clinicalcharacteristicsandoutcomesofpatientswithcovid19andstemitreatedwithfibrinolytictherapy AT sanchezjorgesanz tctconnect213clinicalcharacteristicsandoutcomesofpatientswithcovid19andstemitreatedwithfibrinolytictherapy AT aldujeilimontazar tctconnect213clinicalcharacteristicsandoutcomesofpatientswithcovid19andstemitreatedwithfibrinolytictherapy AT alobeidiammar tctconnect213clinicalcharacteristicsandoutcomesofpatientswithcovid19andstemitreatedwithfibrinolytictherapy AT diezgiljosel tctconnect213clinicalcharacteristicsandoutcomesofpatientswithcovid19andstemitreatedwithfibrinolytictherapy AT zaliunasremigijus tctconnect213clinicalcharacteristicsandoutcomesofpatientswithcovid19andstemitreatedwithfibrinolytictherapy AT stolerrobert tctconnect213clinicalcharacteristicsandoutcomesofpatientswithcovid19andstemitreatedwithfibrinolytictherapy AT mcculloughpeter tctconnect213clinicalcharacteristicsandoutcomesofpatientswithcovid19andstemitreatedwithfibrinolytictherapy |